# A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects

> **NCT07444385** · PHASE1 · RECRUITING · sponsor: **Addpharma Inc.** · enrollment: 44 (estimated)

## Conditions studied

- Benign Prostatic Hyperplasia

## Interventions

- **DRUG:** AD-116, AD-1161

## Key facts

- **NCT ID:** NCT07444385
- **Lead sponsor:** Addpharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-26
- **Primary completion:** 2026-04-22
- **Final completion:** 2026-05-08
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07444385

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07444385, "A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT07444385. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*